Insider Trading: Alkermes Plc (ALKS.O)

ALKS.O on Nasdaq

45.46USD
10:45am EDT
Price Change (% chg)

$0.18 (+0.40%)
Prev Close
$45.28
Open
$45.57
Day's High
$45.82
Day's Low
$45.27
Volume
145,244
Avg. Vol
876,860
52-wk High
$54.25
52-wk Low
$34.28

Search Stocks
EHRICH ELLIOT W
Trading Date Type Shares Traded Price Shares Held
10 Aug 2014 Buy 16,667 $11.74 22,973
10 Aug 2014 Sell 16,667 $41.65 22,973
8 Jul 2014 Sell 14,400 $47.29 22,973
8 Jul 2014 Buy 16,667 $11.74 22,973
8 Jul 2014 Sell 2,267 $48.17 22,973
18 Jun 2014 Buy 17,282 $11.74 22,973
18 Jun 2014 Sell 17,282 $47.10 22,973
8 Jun 2014 Sell 16,667 $48.15 22,973
8 Jun 2014 Buy 16,667 $11.74 22,973
27 May 2014 Buy 3,750 $0.00 22,973
27 May 2014 Sell 1,769 $45.74 22,973
21 May 2014 Sell 2,378 $44.49 20,992
20 May 2014 Sell 1,981 $44.00 23,370
20 May 2014 Sell 2,122 $44.48 23,370
20 May 2014 Buy 4,500 $0.00 23,370
19 May 2014 Buy 3,750 $0.00 23,370
19 May 2014 Sell 1,769 $43.98 23,370
18 May 2014 Sell 2,206 $43.55 20,992
16 May 2014 Buy 4,175 $0.00 20,992
16 May 2014 Sell 1,969 $43.59 20,992
4 May 2014 Sell 2,093 $47.75 20,992
4 May 2014 Buy 2,000 $20.79 20,992
4 May 2014 Buy 5,376 $18.60 20,992
4 May 2014 Sell 870 $47.75 20,992
17 Feb 2014 Sell 7,718 $52.45 16,579

Institutional Holders

% Shares Owned: 97.21%
# of Holders: 276
Total Shares Held: 141,759,220
3 Mo. Net Change: -157,824
# New Positions: 1
# Closed Positions: 4
# Increased Positions: 13
# Reduced Positions: 10
# Net Buyers: 3

Officers & Directors

Name Age Since Current Position

Richard Pops

52 2011 Chairman of the Board, Chief Executive Officer

Shane Cooke

51 2011 President

James Frates

47 2011 Chief Financial Officer, Senior Vice President

Gordon Pugh

55 2011 Chief Operating Officer, Senior Vice President, Chief Risk Officer

Kathryn Biberstein

54 2011 Senior Vice President, Chief Compliance Officer, General Counsel, Secretary

Rebecca Peterson

38 Senior Vice President

James Botkin

64 2011 Senior Vice President - Operations

Elliot Ehrich

54 2011 Senior Vice President - Research and Development, Chief Medical Officer

Michael Landine

60 2011 Senior Vice President - Corporate Development

Srdjan Stankovic

57 2013 Senior Vice President - Clinical Development

Mark Stejbach

50 2012 Senior Vice President, Chief Commercial Officer

Peter Norman

2013 Vice President - Government Affairs and Policy

Paul Mitchell

60 2012 Lead Independent Director

Nancy Wysenski

56 2013 Director

David Anstice

66 2011 Independent Director

Floyd Bloom

76 2011 Independent Director

Robert Breyer

69 2011 Independent Director

Wendy Dixon

58 2011 Independent Director

Geraldine Henwood

59 2011 Independent Director
Search Stocks